tirzepatide fda label For What Use Tirzepatide Wins FDA Approval for

However, survey respondents indicated there were several different ways that patients reduced their GLP-1 doses, with 48% saying they took smaller injections than prescribed, 43% saying they split their doses over a longer period of time, 6% admitting using leftover medication from a friend or family member, and 1% indicating they used expired or leftover medication from a past prescription

This pathway is the major source of energy for the heart [120]

This practice is common but should only be done under the strict supervision of a physician who understands the risks and benefits

Never leave GLP-1 in a hot car, direct sunlight, or unheated environments, as heat accelerates peptide degradation

There is no established direct causal mechanism by which GLP-1 medications damage ocular structures